Serilla-Mab for Refractory Polymyalgia Rheumatica

FDA approved serilla-mab for refractory polymyalgia rheumatica. There have been three RCTs with IL-6 inhibitors recently that I will mention, and I am running a little long. We want to use the lowest dose that adequately controls the symptoms of RA.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app